Peninsula Asset Management Inc Abbott Laboratories Transaction History

Peninsula Asset Management Inc

$186 Million
Q4 2024

A detailed history of Peninsula Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Peninsula Asset Management Inc holds 28,562 shares of ABT stock, worth $3.77 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

28,562

Previous 28,937 1.3%

Holding current value

$3.77 Million

Previous $3.3 Million 2.09%

% of portfolio

1.73%

Previous 1.68%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $41,973 - $44,771	-375 Reduced 1.3%	28,562 $3.23 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $22,815 - $26,933	-228 Reduced 0.78%	28,937 $3.3 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $12,591 - $14,055	-125 Reduced 0.43%	29,165 $3.03 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $8,214 - $9,072	-75 Reduced 0.26%	29,290 $3.33 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $16,685 - $20,424	-185 Reduced 0.63%	29,365 $3.23 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $45,376 - $54,444	-475 Reduced 1.58%	29,550 $2.86 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $33,257 - $37,055	-330 Reduced 1.09%	30,025 $3.27 Million
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $55,694 - $65,555	-575 Reduced 1.86%	30,355 $3.07 Million
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $121,676 - $142,745	-1,280 Reduced 3.97%	30,930 $3.4 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $5,321 - $6,161	-55 Reduced 0.17%	32,210 $3.12 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $108,704 - $131,389	-1,065 Reduced 3.2%	32,265 $3.51 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $3,990 - $4,866	35 Added 0.11%	33,330 $3.94 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $56,725 - $69,456	-491 Reduced 1.45%	33,295 $4.69 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $131,359 - $145,321	1,126 Added 3.45%	33,786 $3.99 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $18,090 - $21,294	-171 Reduced 0.52%	32,660 $3.79 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $101,330 - $119,382	931 Added 2.92%	32,831 $3.94 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $14,175 - $15,446	135 Added 0.42%	31,900 $3.49 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $38,488 - $46,741	-420 Reduced 1.3%	31,765 $3.46 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $55,589 - $71,148	-726 Reduced 2.21%	32,185 $2.94 Million
Q1 2020 May 21, 2020	BUY	$62.82 - $91.86 $216,163 - $316,090	3,441 Added 11.68%	32,911 $2.6 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $49,068 - $54,625	625 Added 2.17%	29,470 $2.56 Million
Q3 2019 Nov 15, 2019	BUY	$81.84 - $88.74 $51,968 - $56,349	635 Added 2.25%	28,845 $2.41 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $68,142 - $79,475	935 Added 3.43%	28,210 $2.37 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $1.81 Million - $2.18 Million	27,275 New	27,275 $2.18 Million

Others Institutions Holding ABT

# of Institutions

3,356

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peninsula Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Peninsula Asset Management Inc with notifications on news.

Account

Peninsula Asset Management Inc Abbott Laboratories Transaction History